GYNECARE TVT™ is a lightweight mesh used in a minimally invasive, effective outpatient treatment for stress urinary incontinence (SUI).
With over 1.5 million women treated worldwide1 – more than any other incontinence treatment of its type – GYNECARE TVT™ is clinically proven, safe and effective.
Most patients experience immediate results with significantly less or no bladder leakage. Moreover, 93% of women surveyed following treatment with GYNECARE TVT™ were still dry or had significantly less bladder leakage 11 years later!2
These women were so satisfied with the treatment that 97% claimed they would recommend the GYNECARE TVT™ procedure to a friend.2
GYNECARE TVT™ is designed to stop urine leakage the way your body was designed to – by supporting your urethra.
Normally, the urethra is supported by the pelvic floor muscles to maintain a tight seal and prevent involuntary urine leakage. In women with SUI, weakened pelvic floor muscles and connective tissue can't support the urethra in its normal position, which is why urine leakage occurs.
To correct this, your doctor will insert a ribbon-like strip of mesh, under the urethra to provide support whenever you stress this area, such as during a cough or sneeze. This helps the urethra to remain closed when appropriate, preventing involuntary urine leakage.
You may be a candidate for GYNECARE TVT™ even if you have undergone surgical treatments for incontinence in the past. A doctor can help you assess whether GYNECARE TVT™ may be right for you.
You are not a candidate for GYNECARE TVT™ if you are pregnant or plan on becoming pregnant, or if you are currently taking an anticoagulant therapy.
Again, a doctor can help you make the best treatment choice. Start by talking about your symptoms. He or she will be able to help you evaluate treatment options that work best for you.
| References: | |
| 1. | Data on file. Ethicon, Inc. Somerville, NJ |
| 2. | Nilsson C G, Palva K, Rezapour M, Falconer C. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence. Int Urogynecol J. 2008;19:1043-1047. |